Missouri Valley Cancer Consortium — Omaha, Nebraska

Missouri Valley Cancer Consortium is a clinical research site located in Omaha, Nebraska, United States 68106.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Missouri Valley Cancer Consortium has participated in 78 clinical trials with 22 currently active.

Therapeutic areas: Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Missouri Valley Cancer Consortium?

Missouri Valley Cancer Consortium has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Missouri Valley Cancer Consortium conducted?

Missouri Valley Cancer Consortium has 78 clinical trials on record, with 22 currently active. Their work covers Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Is Missouri Valley Cancer Consortium accredited by Crixeo Health?

Missouri Valley Cancer Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Missouri Valley Cancer Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.